Midyear
2012 has drawn to a close as one of the more difficult years for natural
resource investing in recent
memory.
The main drivers of this commodity
sell-off were slowing growth in both China and the U.S.
and,
even more critically, an accelerating deterioration in Europe.
For the
Period Ending June 30, 2012 the portfolio I managed has outperformed and has
shown positive returns mainly due to my underweight in the energy sector which
is approximately 6 % of my overall portfolio compare to a weight of 26% for the
S&P/TSX index.
To put this into perspective the top two largest
holdings of my portfolio are Coca-Cola (4.3
% weighting) and Merck (3.4 % weighting)
is greater than my total energy
weighting and both have outperformed . Coca-Cola
is up 73.09 % and Merck is up 23.22 % since I added both to the portfolio. Last week
the shares of Merck jumped 4% in early trading Thursday, the day after it
said it was ending a key Phase III clinical trial for its osteoporosis drug
candidate odanacatib ahead of schedule because the drug had been shown to be
highly effective.
The Focus Stock for the month is
Coca-Cola, which carries S&P Capital IQ’s highest investment recommendation of 5-STARS, or strong buy. Coca-Cola, based in Atlanta, GA, is the
world’s largest producer of soft drink concentrates and syrups, as well as the
world’s biggest producer of juice and juice-related products. The company also
owns or has majority stakes in 97 beverage bottling or canning plants located
around the world, which are consolidated into the Bottling Investments
operating segment. Coca Cola operates in more than 200 different countries, I
see that providing a steady runway for future growth as well as strong opportunities
to increase per capita consumption.
Moreover, I still find the valuation of
the shares compelling, trading in the lower half of KO’s historical average
with a dividend yield approaching 3%